drugset / Trial / NCT04873531
Feasibility of Neostigmine for Intraoperative Neuromonitoring in Thyroid Surgery
RandomizedParallel-groupDouble-blindPrevention
Summary
For successful intraoperative neuromonitoring (IONM), adequate reversal of neuromuscular blocking agent is a prerequisite in thyroid surgery with . The aim of this study is to investigate the feasibility of neostigmine just after tracheal intubation on the IONM in thyroid surgery.
Timeline
- Start
- 2021-05-10
- Primary completion
- 2021-08-23
- Completion
- 2021-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neostigmine | Other / unclassified | 0.03 ug/kg | — |
| Background | Glycopyrrolate | Small molecule | — | — |